Logo

MOH

Molina Healthcare, Inc.

MOH

Molina Healthcare, Inc. • NYSE
$148.26 ▼ -0.05% (-0.07)
Market Cap $8.03 B
52w High $359.97
52w Low $133.40
Dividend Yield 0%
P/E 9.13
Volume 484.54K
Outstanding Shares 54.17M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $20.993B ▲ $729M ▼ $79M ▼ 0.376% ▼ $1.51 ▼ $182M ▼
Q2-2025 $11.427B ▲ $794M ▼ $255M ▼ 2.232% ▼ $4.76 ▼ $431M ▼
Q1-2025 $11.147B ▲ $847M ▲ $298M ▲ 2.673% ▲ $5.47 ▲ $481M ▲
Q4-2024 $10.499B ▲ $733M ▲ $251M ▼ 2.391% ▼ $4.37 ▼ $428M ▼
Q3-2024 $10.34B $722M $326M 3.153% $5.66 $514M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $8.447B ▼ $15.698B ▼ $11.507B ▼ $4.191B ▼
Q2-2025 $8.809B ▼ $16.209B ▼ $11.606B ▼ $4.603B ▲
Q1-2025 $9.294B ▲ $16.386B ▲ $12.076B ▲ $4.31B ▼
Q4-2024 $8.987B ▼ $15.63B ▼ $11.134B ▲ $4.496B ▼
Q3-2024 $9.214B $15.758B $10.988B $4.77B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $79M ▼ $-125M ▲ $77M ▼ $-220M ▼ $-268M ▲ $-163M ▲
Q2-2025 $255M ▼ $-302M ▼ $128M ▲ $-189M ▼ $-363M ▼ $-344M ▼
Q1-2025 $298M ▲ $190M ▲ $-123M ▼ $147M ▲ $214M ▲ $168M ▲
Q4-2024 $251M ▼ $-224M ▼ $19M ▲ $67M ▲ $-138M ▼ $-235M ▼
Q3-2024 $326M $873M $-48M $-364M $461M $838M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Marketplace
Marketplace
 $610.00M ▲$1.00Bn ▲$1.20Bn ▲$1.20Bn ▲
Medicaid Solutions Segment
Medicaid Solutions Segment
 $6.68Bn ▲$8.13Bn ▲$8.03Bn ▼$8.02Bn ▼
Medicare
Medicare
 $1.24Bn ▲$1.47Bn ▲$1.61Bn ▲$1.61Bn ▲
Other Segments
Other Segments
 $20.00M ▲$50.00M ▲$50.00M ▲$40.00M ▼

Five-Year Company Overview

Income Statement

Income Statement Molina’s income statement shows a company that has grown significantly over the last five years while keeping its operations profitable and relatively disciplined. Revenue has expanded strongly, helped by membership growth and acquisitions. Gross profit and operating profit have both risen, which suggests the company has generally been able to price its plans and manage medical costs well enough to grow earnings. Net income and earnings per share have climbed meaningfully, though profit growth has been a bit less explosive than revenue growth, hinting at some ongoing pressure from medical cost inflation and contract pricing. Overall, it looks like a mature but still expanding managed care business with solid, if not flawless, profit discipline.

Balance Sheet

Balance Sheet The balance sheet looks sturdier than it did five years ago. Total assets and shareholders’ equity have both grown, indicating a larger and better-capitalized platform. Debt has increased, but not in a way that appears extreme relative to the size of the business, and the company keeps a sizable cash balance. That combination—larger equity base, manageable leverage, and healthy cash—points to improved financial flexibility. The main watchpoint is that Molina is still a contract-heavy, regulated insurer: its real strength lies less in hard assets and more in its contracts, risk models, and regulatory relationships, which do not show up fully on the balance sheet.

Cash Flow

Cash Flow Cash generation is consistently positive but somewhat uneven from year to year. Molina has produced solid free cash flow over the period, and its spending on physical assets is modest, which supports a cash-light, service-based model. However, operating cash flow has swung around, likely reflecting the timing of premium receipts, claims payments, and settlements with states. This is common in government-focused health plans but means that single-year cash figures can look noisy. Overall, the pattern suggests the business converts earnings into cash reasonably well over time, with working-capital timing as the main source of volatility.

Competitive Edge

Competitive Edge Molina occupies a focused niche as a specialist in government-sponsored healthcare, particularly Medicaid, Medicare, and dual-eligible populations. Its edge comes from deep experience with complex state and federal programs, tight cost control, and a repeatable playbook for taking over and improving underperforming plans. This specialization creates meaningful barriers to entry, as new competitors must master regulation, bidding, and care management for very complex patient groups. At the same time, Molina faces intense competition from much larger insurers when contracts are rebid, and it is heavily exposed to political and regulatory decisions on reimbursement rates and program design. The franchise looks strong within its lane but structurally tied to policy risk and contract renewals.

Innovation and R&D

Innovation and R&D While Molina does not do traditional lab-style R&D, it invests in data, analytics, and care models that function as its innovation engine. The company uses artificial intelligence and predictive analytics to identify high-risk members, personalize care plans, and help prevent fraud, which can both improve outcomes and control costs. Partnerships in virtual care and remote monitoring expand access for members with chronic conditions, especially in underserved communities. Molina is also leaning into specialized products like dual-eligible plans and marketplace offerings that preserve continuity of care, and it is integrating social factors such as housing, food, and employment into its health programs. The main opportunity is to keep scaling these tools without losing focus or stretching technology and operations beyond what they can reliably manage.

Summary

Molina Healthcare today looks like a larger, more profitable version of itself compared with five years ago, built around a clear focus on government-sponsored programs and vulnerable populations. Financially, it shows healthy revenue and earnings growth, a stronger capital base, and steady free cash flow, though cash and margins are subject to swings from medical cost trends and contract dynamics. Competitively, its expertise in Medicaid and Medicare, cost management, and acquisitions gives it a defensible position, even as it competes with much bigger national players and faces constant regulatory and pricing risk. The company’s push into analytics-driven care management, virtual health, and integrated dual-eligible offerings suggests a willingness to innovate inside a conservative, highly regulated framework. Going forward, the key questions center on its ability to keep winning and integrating new contracts, secure adequate reimbursement to offset rising medical costs, and sustain operational discipline as it grows in a challenging policy and cost environment.

NEWS

November 29, 2025 · 10:21 PM UTC

MOH DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important December 2 Deadline in Securities Class Action - MOH

Read more

November 29, 2025 · 8:19 AM UTC

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare

Read more

November 28, 2025 · 5:43 PM UTC

Molina Healthcare 96 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Molina Healthcare, Inc. - MOH

Read more

November 28, 2025 · 12:00 PM UTC

MOH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Read more

November 28, 2025 · 11:13 AM UTC

Bragar Eagel & Squire, P.C. Urgently Reminds Stockholders of Spirit and Molina to Contact the Firm Before Upcoming Deadlines

Read more